A lot has changed since New York’s Marijuana Regulation and Taxation Act was signed into law on March 31, 2021. What began as a long-promised reset of cannabis policy has, in just a few years, become a sprawling, fast-moving ecosystem that touches public health, consumer culture, global trade, and the daily rhythms of communities across the state. Since the first legal dispensary opened on December 29, 2022, 581 licensed cannabis retailers have come online statewide, transforming once-abstract debates into brick-and-mortar reality.
With that expansion has come both momentum and friction. Legal markets are posting eye-popping sales numbers, in New York and beyond, even as regulators race to keep pace with enforcement, equity commitments, and a still-evolving federal landscape. At the same time, cannabis research is maturing, producing findings that complicate easy narratives—suggesting potential benefits in some contexts, raising red flags in others, and often landing in frustrating gray zones where the science is still catching up to consumer enthusiasm.
Sit, Stay, Chill
A major recent analysis of data from the Dog Aging Project—covering more than 47,000 US companion animals—suggests that long-term use of cannabidiol (CBD) supplements is linked with a reduction in aggressive behavior in dogs over time.
Researchers found that dogs given regular CBD or hemp products were typically older and more likely to have conditions like dementia, osteoarthritis, or cancer. While these dogs were described as more aggressive initially, owners reported that their aggression became noticeably less intense with prolonged CBD use compared with dogs that never received the supplements.
The study, published in Frontiers in Veterinary Science, did not find similar effects on anxiety or other behaviors, and scientists stress that more controlled research is needed to confirm CBD’s potential calming effects and determine safe dosing.
Source: Frontiers in Veterinary Science
Cannabis Drinks as an Alcohol Alternative
Cannabis-infused beverages may offer a harm-reduction alternative to alcohol, according to new research highlighted by industry advocates. A study presented at the 2026 International Cannabis Research Conference suggests that adults who choose THC or CBD drinks instead of traditional alcoholic beverages may experience fewer negative consequences, such as hangovers, risky behavior, and impaired next-day functioning. Researchers found that consumers reported these cannabis drinks as enjoyable social options that helped them reduce their overall alcohol intake without sacrificing the ritual of shared drinks.
While the findings are preliminary and based on self-reported behavior rather than controlled clinical trials, proponents say the trend could help shift drinking culture—particularly if products are developed with clear dosing, slower onset, and responsible marketing. Critics urge more rigorous research to understand long-term effects and ensure public health safeguards keep pace with innovation.
Source: Journal of Psychoactive Drugs
The CBD Clock Is Ticking
Millions of Americans who use cannabidiol (CBD) for pain, sleep, anxiety, and general wellness could see many products disappear from the market later this year under sweeping federal changes to hemp law. A little-noticed provision tucked into the funding bill that reopened the US government in late 2025 redefines federally legal hemp—tightening limits on THC and total cannabinoids allowed in hemp-derived products.
Under the new definition, many common CBD oils, tinctures, gummies, beverages, topicals, and other consumer products exceed allowable THC thresholds and could become illegal when the rule takes effect in November 2026, unless Congress acts to revise or delay the change.
The looming ban reflects ongoing federal anxiety about unregulated intoxicating cannabinoids, but it also threatens the established multi-billion-dollar hemp CBD market.
Source: New York Times
Massachussetts Tops $9B in Legal Cannabis Sales
Massachusetts’ regulated cannabis market has hit a major revenue milestone: total adult-use recreational marijuana sales have now surpassed $9 billion since the program launched in 2018, state officials report. As of early February 2026, the Commonwealth recorded $1.65 billion in purchases in 2025 alone, with sales already climbing this year, including a notable surge ahead of the late-January snowstorm.
Regulators say the achievement underscores the enduring strength of the legal market and its role in shifting consumers away from unregulated sources, while generating jobs, investment, and tax revenue for public programs. Flower continues to dominate purchases, followed by vape products and pre-rolls, reflecting broad adult consumer demand. As Massachusetts continues to refine its regulatory framework and explore outlets like social consumption lounges, officials anticipate further growth and industry maturation.
Source: Massachusetts Cannabis Control Commission
Big Claims, Thin Evidence
A new scientific review highlights a big gap between the popularity of medical cannabis and the strength of evidence supporting its effectiveness, despite millions of Americans using it for a range of health issues. Researchers evaluated more than 2,500 studies and concluded that clear clinical benefits are limited to a small set of conditions—such as certain seizure disorders, chemotherapy-induced nausea, and appetite stimulation in serious illnesses—primarily through FDA-approved cannabinoid medicines. For the most common reasons people use cannabis—chronic pain, anxiety, and insomnia—the evidence is weak, inconsistent, or inconclusive. Critics of the research say more high-quality studies are needed, but for now the science doesn’t strongly back many of the therapeutic claims made in dispensaries or by enthusiastic users.
Source: JAMA
When Weed and Young Minds Collide
A new study out of Ontario, Canada, finds a notable rise in psychotic disorder diagnoses among adolescents and young adults, with researchers pointing tocannabis use as a likely contributing factor. Rates of diagnosed psychosis—including conditions such as schizophrenia—have climbed significantly in younger cohorts compared with older generations, even as overall rates remain stable or decline among adults.
Experts suggest the trend reflects a mix of influences, such as improved detection and broader access to mental health care, alongside greater use of psychoactive substances like cannabis among youth. Though the study does not definitively prove causation, researchers note that cannabis—especially high-THC products—may exacerbate underlying vulnerabilities in the developing brain and elevate risk for psychotic symptoms or disorders. The findings underscore emerging public health concerns as cannabis use becomes more common and perceptions of harm decline among young people.
Source: Canadian Medical Association Journal
New York Market Snapshot
New York’s legal cannabis market entered 2026 with clear momentum and a widening footprint. Retail sales hit $1.69 billion in 2025, with another $127.1 million logged early this year, as the number of open dispensaries climbed to 582 statewide. Nearly half of December 2025 sales came from stores that opened last year, underscoring how quickly new operators are shaping the market.
As of January, the state had issued 2,110 active adult-use licenses across cultivation, processing, distribution, retail, and microbusinesses, reflecting the continued build-out of supply and infrastructure. Equity remains central to that expansion: 57 percent of all licenses have gone to Social and Economic Equity applicants, alongside 324 active CAURD licensees.
Source: Office of Cannabis Management
Weed Without Borders
High-potency marijuana grown in California has become so coveted in the United Kingdom that British authorities are intercepting a steady stream of illicit shipments from the US—often hidden in passenger luggage on flights. According to British law enforcement, smugglers are exploiting the contrast between California’s legal recreational market and the UK’s strict cannabis laws, tapping demand for strong, high-THC product overseas. Officials report that vacuum-packed cannabis is being seized at an average rate of about five incidents per month in 2025, with travelers caught trying to bring California weed home, despite severe penalties under UK drug importation law. The trend reflects both the allure of “Cali weed” abroad and the broader challenges that international drug trafficking poses even when cannabis is legal in source jurisdictions, prompting warnings from border agencies about the legal risks of transporting marijuana across international boundaries.
Source: Daily Mail
Rhinebeck Shop Shut in Statewide Sweep
State regulators stepped up enforcement against New York’s illicit cannabis market this month, seizing more than $2 million in illegal products across the Mid-Hudson Valley and New York County. In one of the largest actions, investigators from the Office of Cannabis Management shut down an illegal operation in Rhinebeck on February 10. The site was being used to grow, process, store, and sell unlicensed cannabis. Authorities recovered 105 pounds of flower, 73 pounds of edibles, and five pounds of cannabis concentrate, with an estimated value of more than $900,000, and issued an Order to Seal, padlocking the building.
“These enforcement actions send a clear message,” said Daniel Haughney, noting that illegal operators face scrutiny in both urban and rural communities. So far in 2026, OCM has closed 22 illegal shops, contributing to 557 illicit storefronts shut statewide as regulators work to protect the legal market and public safety.
Source: Office of Cannabis Management
This article appears in March 2026.
